[144] iOThree Limited SEC Filing

Rhea-AI Filing Summary

Moelis & Company (MC) filed a Form 4 reporting equity awards granted to non-employee director Kenneth Shropshire on 1 July 2025.

• 1,761 2025 Annual Restricted Stock Units (RSUs) were awarded at a reference price of $62.45 (average closing price for the five trading days ended 30 June 2025). The units vested immediately on the grant date, with share settlement scheduled within 60 days after 1 July 2027.
• 208 2025 Elective RSUs were awarded on the same date. These RSUs vest in four equal quarterly installments, concluding on 1 July 2026, and are settled within 60 days of each vesting date.
• Each RSU entitles the holder to receive one share of Class A common stock. Following the transactions, Shropshire beneficially owns the exact number of RSUs granted (1,761 and 208, respectively), reported as direct ownership.

The filing reflects routine director compensation rather than an open-market purchase or sale; therefore, immediate market impact is expected to be neutral.

Insights

Financial Analyst

TL;DR – Routine equity grant; neutral signal for MC shareholders.

The Form 4 shows standard RSU compensation to an outside director, totaling 1,969 units valued at the grant reference price of $62.45. Because the award is part of Moelis & Co.’s normal director program, involves no cash transaction, and the shares are subject to multi-year settlement schedules, it does not alter the firm’s capital structure or convey new information about operating performance. Insider alignment is marginally positive, but the small size versus MC’s float renders the event not impactful for valuation or liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Eddid Securities USA Inc. 40 Wall Street, Suite 1606, New York, NY 10005	2037500	794013.00	25650000	07/10/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	02/08/2024	IPO reorganization	Issuer			4894352	02/08/2024	Share exchange

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider transaction did Moelis & Company (MC) disclose on Form 4?

Director Kenneth Shropshire received 1,761 Annual RSUs and 208 Elective RSUs on 1 July 2025.

When do the 2025 Annual RSUs for MC vest and settle?

They vested on 1 July 2025 and will settle in shares within 60 days after 1 July 2027.

What is the vesting schedule for the 2025 Elective RSUs granted to the MC director?

Elective RSUs vest in four equal quarterly tranches, ending on 1 July 2026, with settlement within 60 days of each vesting date.

How many shares can the director receive from the RSU grants?

Each RSU converts into one Class A share, totaling 1,969 potential shares (1,761 + 208).

Did the director buy or sell Moelis & Company stock on the open market?

No. The Form 4 reports equity awards, not open-market purchases or sales.